273 related articles for article (PubMed ID: 23557834)
1. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.
Dretzke J; Meadows A; Novielli N; Huissoon A; Fry-Smith A; Meads C
J Allergy Clin Immunol; 2013 May; 131(5):1361-6. PubMed ID: 23557834
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.
Meadows A; Kaambwa B; Novielli N; Huissoon A; Fry-Smith A; Meads C; Barton P; Dretzke J
Health Technol Assess; 2013 Jul; 17(27):vi, xi-xiv, 1-322. PubMed ID: 23827204
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses.
Tie K; Miller C; Zanation AM; Ebert CS
Laryngoscope; 2022 Mar; 132(3):499-508. PubMed ID: 33929726
[TBL] [Abstract][Full Text] [Related]
5. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
Nelson H; Cartier S; Allen-Ramey F; Lawton S; Calderon MA
J Allergy Clin Immunol Pract; 2015; 3(2):256-266.e3. PubMed ID: 25609326
[TBL] [Abstract][Full Text] [Related]
6. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
Durham SR; Penagos M
J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
[TBL] [Abstract][Full Text] [Related]
7. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.
Dranitsaris G; Ellis AK
J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis.
Devillier P; Dreyfus JF; Demoly P; Calderón MA
BMC Med; 2014 May; 12():71. PubMed ID: 24885894
[TBL] [Abstract][Full Text] [Related]
9. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.
Kim JM; Lin SY; Suarez-Cuervo C; Chelladurai Y; Ramanathan M; Segal JB; Erekosima N
Pediatrics; 2013 Jun; 131(6):1155-67. PubMed ID: 23650298
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
Yang J; Lei S
Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
12. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of subcutaneous versus sublingual immunotherapy for allergic rhinitis: current update.
Chelladurai Y; Lin SY
Curr Opin Otolaryngol Head Neck Surg; 2014 Jun; 22(3):211-5. PubMed ID: 24732432
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study.
Khinchi MS; Poulsen LK; Carat F; André C; Hansen AB; Malling HJ
Allergy; 2004 Jan; 59(1):45-53. PubMed ID: 14674933
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.
Kim JY; Jang MJ; Kim DY; Park SW; Han DH
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4450-4458.e6. PubMed ID: 34464748
[TBL] [Abstract][Full Text] [Related]
18. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
